Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Nina Rica Wium Geiker, Centre for Childhood Health, Copenhagen, Denmark
Another FDA approval was received in December 2022, expanding the use of Wegovy to adolescents aged 12 and older who meet the BMI (Body Mass Index) criteria
Laboratory research catalog Tirzepatide is available in 10mg, 20 mg, and 60 mg laboratory research formats
Patients with non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD) with concurrent diabetes or obesity might benefit from the hepatic anti-inflammatory effects observed in clinical studies, though GLP-1 receptor agonists are not yet FDA-approved specifically for liver disease
1 Trial design
US$ 24.24
US$ 29.19
US$ 28.12
US$ 20.20
US$ 20.30
US$ 26.15
